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Abstract
Objective: Comparative evaluation of costs and effects of laparoscopic hysterectomy (LH) and abdominal hysterectomy
(AH).
Data sources: Controlled trials from Cochrane Central register of controlled trials, Medline, Embase and prospective trial
registers.
Selection of studies: Twelve (randomized) controlled studies including the search terms costs, laparoscopy, laparotomy and
hysterectomy were identified.
Methods: The type of cost analysis, perspective of cost analyses and separate cost components were assessed. The direct
and indirect costs were extracted from the original studies. For the cost estimation, hospital stay and procedure costs were
selected as most important cost drivers. As main outcome the major complication rate was taken.
Findings: Analysis was performed on 2226 patients, of which 1013 (45.5%) in the LH group and 1213 (54.5%) in the AH
group. Five studies scored $10 points (out of 19) for methodological quality. The reported total direct costs in the LH group
($63,997) were 6.1% higher than the AH group ($60,114). The reported total indirect costs of the LH group ($1,609) were half
of the total indirect in the AH group ($3,139). The estimated mean major complication rate in the LH group (14.3%) was
lower than in the AH group (15.9%). The estimated total costs in the LH group were $3,884 versus $3,312 in the AH group.
The incremental costs for reducing one patient with major complication(s) in the LH group compared to the AH group was
$35,750.
Conclusions: The shorter hospital stay in the LH group compensates for the increased procedure costs, with less morbidity.
LH points in the direction of cost effectiveness, however further research is warranted with a broader costs perspective
including long term effects as societal benefit, quality of life and survival.
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Introduction
Traditionally abdominal hysterectomy (AH) is the standard
procedure for gynecological malignancy and several benign
indications and remains the ‘fallback option’ if the uterus cannot
be removed by another approach. While the abdominal surgical
approach is an accepted effective treatment, it is associated with
substantial morbidity, mostly wound problems on the short-term
([1–3] and incisional hernias on the long-term [4]. A good
alternative approach for patients with an indication for removal of
the uterus is by laparoscopy. The laparoscopic approach to
hysterectomy has evolved over the last 20 years. In 1984, Kurt
Semm [5] introduced laparoscopic assistance to complicated
vaginal hysterectomy and this was followed by laparoscopically
assisted vaginal hysterectomy as described by Harry Reich [6].
Three types of laparoscopic hysterectomy (LH) are currently
practiced: Laparoscopically Assisted Vaginal Hysterectomy
(LAVH), Total Laparoscopic Hysterectomy (TLH) and Laparo-
scopically Assisted Supracervical Hysterectomy (LASH). The
laparoscopic approach has the advantages of laparotomy, i.e.
possibility of thorough abdominal inspection to assess the
abdominal cavity for extra-uterine spread and collection of
peritoneal fluid for cytology. Moreover, since patients do not
have a large abdominal wound, the laparoscopic approach results
in a shorter hospital stay, less abdominal wound morbidity and
quicker return to activity in daily life [1,2]. Nevertheless, for
several reasons laparoscopy is not an established procedure for all
indications for abdominal hysterectomy yet. The first reason is
inexperience of surgeons with this advanced laparoscopic
procedure, which results in a higher peri-operative complication
rate during the learning curve [7]. Next reason is economic: higher
per-operative costs, longer operation time, expensive surgical
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However, laparoscopic approaches to hysterectomy offer the
prospect of improved outcomes and gains in cost effectiveness
through better and quicker convalescence and shorter length of
inpatient stay.
A combination of the development of expensive new treatments
for patients, the limited budgets available for health care and the
increasing demands on the health system has led to a need to
evaluate the costs in addition to clinical effects, in order to make
rational decisions regarding the acceptance of new treatments into
the health service.
Therefore, it is important to determine the actual costs of a new
treatment and to compare those with the costs of the standard
treatment, in order to give this new method a chance to be fairly
judged and further propagated. With the exception of some
observational studies [8–10] and small randomized trials [11,12],
little is known about the costs and cost effectiveness of LH relative
to the conventional abdominal approach. Our aim of this study is
to pool the data of controlled trials and review whether this new
health technology, laparoscopic hysterectomy, provides ‘good
value for money’ in comparison to the conventional procedure.
Methods
Search strategy
The methodology of the review was according to the
QUORUM statement [13] (appendix S1). Studies comparing
the costs and cost effectiveness of LH versus AH were sought from
a systematic review of the literature. The electronic databases
Medline, Embase and the Cochrane library database were
searched for relevant articles between the years 1990 and 2008.
Prospective clinical trial registers were also searched for the same
keywords. Search terms used were: costs, laparoscopy, laparotomy
and hysterectomy. The references of all relevant articles were
hand-searched for any previously missed articles. The results of the
search in electronic databases and the hand search were indicated
in the flowchart (figure 1).
Selection of trials
All studies that compared costs between AH and all forms of LH
were included in this review. Studies were excluded from the
review if they made comparisons other than those specified above.
There was no restriction to any language. Furthermore, reviews,
letters, author’s replies, retrospective studies and case series with
no control group were excluded, whereas prospective controlled
studies and randomized controlled trials were included. Papers
were independently appraised by two authors (KV, CB) in terms of
their methodology and design by using a predetermined protocol
and graded as to the level of evidence (table 1 and 2). Differences
were resolved by discussion between the authors.
The search strategy identified 16 studies [11,12,14–27] that
compared the costs of laparoscopic hysterectomy and abdominal
hysterectomy. Four [23–25,27] of these were not suitable for
further reviewing according to our in- and exclusion criteria. The
flow of studies included in the analysis is presented in figure 1
(based on the QUORUM flowchart) [13].
Data management
All data were extracted independently by two reviewers (KV,
CB) and differences of opinion were resolved by consensus.
Extracted data are presented in detail in appendix S2 and general
study characteristics are shown in table 2. The economic impact of
a surgical procedure can be divided into direct medical costs and
indirect costs. Direct costs relate to health care costs and include
those relating to the hospital stay, operative procedure and
treatment-related complications. Procedure costs relate to the
instruments and equipment used for the procedure, the duration
(including anesthetic time), staff costs and overheads costs of the
theatre. Indirect costs are the societal (because of a loss of
productivity) and individual costs relating to a patient’s absence
from work or normal activities; this also includes costs of carers.
Wherever possible, costs have been classified in this manner,
although some of the studies vary in their definitions.
Analysis of (inter study) costs and effects
Reported costs. The type of cost analysis, perspective of cost
analyses and all separate cost components of the studies were
assessed (table 2 and 3). In case a vaginal hysterectomy arm was
included, these data were excluded from further analysis. The
direct and indirect costs as reported by the authors between the
procedures and within studies were specified and expressed in US
dollar (table 3). No formal meta-analysis could be performed
because of the heterogeneity in the selected studies in terms of date
of publication, currency in which costs were calculated, statistical
method used, disease process examined and particularly the range
of cost components that were included and primary effect
measures which were taken into account.
Estimated costs and effects. To be able to draw a global
conclusion with regard to costs and the ratio between costs and
effects, overall treatment costs were estimated based on costs in the
current situation in Dutch hospitals (table 4 and 5). Costs of the
procedure were estimated based on personnel costs ($4.14 or
J3.12/min), overhead and housing (45%) according to the Dutch
guidelines for costs studies. Costs of disposables ($1,328 or J1,000:
only LH) were globally assessed based on the current Dutch
protocol [28]. Costs of hospital stay were based on Dutch standard
prices (mean of general hospital and university medical center:
$571/J430). The price level used was that of 2007 and costs are
expressed in US dollars ($). Since information on other cost
categories was scarce in most studies, those costs were not included
in the present estimation. As primary effect measure the overall
complication rate as well as the major complication rate was taken.
The division between and definition of major and minor
complications were subtracted from the original article. The
complication rate consists of the reported complications added up
with the amount of re-interventions performed. Conversions to
laparotomy were not considered as complications.
Statistical analysis. All the analyses were done for all
included studies together and a sub-analysis is done for the RCTs
only. Total costs were calculated for each treatment arm in each
study separately. Mean estimated costs with the range (minimum-
maximum) were presented. To compare cost and effect pairs
between studies, both costs and results were re-calculated to the
level of 100 patients per treatment arm. Subsequently, point
estimates of cost and effect pairs were plotted in a cost-effectiveness
plane. These analyses were performed in Microsoft Office Excel
(2003).
Results
Characteristics of selected studies
Of all included trials, 6 of the 12 controlled trials concerned
randomized controlled trials [11,12,17,20–22]. Five studies scored
$10 points (out of 19) for methodological quality. In the majority
of studies (7 out of 12) the costs were analyzed with a cost
consequence analysis, mostly from a hospital perspective. No
influence of funding or sponsoring was reported. In only two
studies, (also) women with a malignant indication for a
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trials varied from a simple hysterectomy to a more extended
hysterectomy with or without lymphadenectomy. Furthermore,
the extent to which the hysterectomy was completed laparoscop-
ically differed from a LAVH to a LSH or a TLH. In total, 2902
patients were included, of which 662 patients underwent a vaginal
hysterectomy or were allocated to a vaginal arm. Analysis was
performed on 2226 patients; 1213 (54.5%) in the LH group and
1013 (45.5%) in the AH group.
The total direct costs of the LH group ($63,997) were 6.1%
higher than the AH group ($60,114). Three studies reported lower
costs for the LH group compared with the AH group [15,18,20].
The total indirect costs of the LH group ($1,609) were half of the
total indirect costs in the AH group ($3,139). A direct relation
between costs and included cost components could not be observed.
Cost components: procedure and hospital stay
From table 4 can be concluded that the mean duration of a
laparoscopic procedure ranges from 81.9 minutes [12] to 200.6
minutes [15]. The weighted mean duration of a laparoscopic
procedure was 127.7 minutes. In two studies other procedures
were performed in addition to the hysterectomy, equally
distributed over both arms [18,19]. Conversely, the shortest mean
duration of an AH was 47.3 minutes [12] and the longest mean
duration 146.0 minutes [22] (table 4). The weighted mean
duration of an AH was 101.3 minutes. The shortest mean hospital
Figure 1. Flowchart of included studies.
doi:10.1371/journal.pone.0007340.g001
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mean hospital stay was 5.1 days and 7.4 days after a LH or an AH,
respectively. The weighted mean hospital stay after a LH was 3.6
days (table 4), whereas the weighted mean hospital stay after an
AH was 4.8 days (table 5). Overall, in each study the mean hospital
stay was lower in the LH group compared to the AH group.
Effect components: overall and major rate
Overall, the mean complication rate was 15.3% in the LH
group and 21.7% in the AH group, with a complication rate
difference of 6.4% (table 4 and 5). The mean major complication
rate was lower in the LH group (14.3%) than in the AH group
(15.9%), with a complication rate difference of 1.6%. An even
stronger trend can be seen from the comparison of minor
complication, 11.0% in the LH group and 23.0% in the AH,
respectively. For the sub-analysis of only RCTs the mean
complication rate was 19.9% in the LH group and 24.6% in the
AH group, with a complication rate difference of 4.7%. The mean
major complication rate was even higher in the LH group (17.8%)
compared to the AH group (16.1%), with a complication
difference of 21.7% (table 4 and 5).
Incremental costs and effects
The estimated mean costs for the procedure were higher in
the LH group $2,226 ($1,807–$2,531) than in the AH group
$648 ($270–$909). In contrast, mean costs for hospital stay were
lower in the LH group ($1,658: $856–$2,795) compared to the
AH group ($2,664: $1,426–$3,424). In sum, the total costs in the
LH group were $3,884 ($3,130–$4,928) and in the AH group
$3,312 ($2,208–$3,767), with a cost difference of $572 between
groups. The incremental costs for reducing one patient with
complication(s) in the LH group compared to the AH group
were $8,938, ($5726100/6.4) re-calculated to a level of 100
patients. When subdivided for major complications, the
incremental costs were $35,750 ($5726100/1.6) for reducing
one patient with major complication(s). For the sub-analysis of
only RCTs, the total costs in the LH group were $3,794
($3,263–$4,451) and in the AH group $3,277 ($2,208–$3,767),
with a cost difference of $517. The incremental costs for
reducing one patient with complication(s) in the LH group
compared to the abdominal group were $11,000 ($5176100/
4.7). Regarding major complications, effects were lower with
higher costs in the LH group. Three point estimates are located
in the north-east quadrant of figure 2a, indicating that these
studies generated extra effects of LH for relatively low
additional costs, within a cost ratio range of $2,895 to $3,552
[11,18,22]. With regard to overall complications, six studies are
located in the north-east quadrant [11,12,14,15,18,22] and
therefore generating extra effects of LH within a cost ratio range
of $1,401 to $6,618 (figure 2b).
Table 1. Methodological quality assessment*.
Category Subcategory score
Generation of allocation sequence Computer generated random number 2
Not described 1
Allocation concealment Central randomization 3
Sealed enveloped or similar 2
Not described or inadequate 1
Outcome assessor blindness Blinded for treatment arm 2
Inadequate blinding 1
Not described or no double-blinding 0
Description of withdrawals and dropouts Numbers and reasons are described 2
Number or reasons are not described 1
Numbers and reasons are not described 0
Efficacy of randomization/controlling Pretreatment variables in tabular form 2
Balance of pretreatment variables mentioned but not in tabular form 1
No information report 0
Analysis include an intention-to treat analysis Intention-to treat analysis described 2
Unclear 1
No intention-to-treat analysis used 0
All important and relevant costs for each arm For direct and indirect costs 2
For direct or indirect costs 1
Incomplete cost analysis 0
Valid measurements and detailed description of costs Yes 2
Unclear 1
No 0
Relevant sensitivity analysis Sensitivity analysis described and in tabular/graphical form 2
Sensitivity analysis described, no tabular/graphical form 1
No sensitivity analysis described 0
*=analogously of Jadad score
doi:10.1371/journal.pone.0007340.t001
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For the first time, costs and short term effects were reviewed
and calculated between laparoscopic hysterectomy and abdom-
inal hysterectomy in a large group of patients. Cost evaluations
for other diseases comparing laparoscopic and open surgery
already published, demonstrated that laparoscopic appendecto-
my, laparoscopic colectomy and laparoscopic cholecystectomy
results in decreased hospital stay,l o w e rh o s p i t a lcost and faster
return to work or daily activities than open procedures [29]. Our
review showed a similar trend with regard to hospital stay and
hospital costs. Twelve trials concerning 2226 patients in total
were reviewed, of which five trials scored $10 points (out of 19)
for methodological quality. As reported by the authors, the direct
costs were higher and indirect costs were lower for LH compared
to AH. Procedure costs were estimated higher and costs of
hospital stay were estimated lower in favor of LH. In the LH
group the estimated overall and major complication rate were
both lower compared to the AH group, 6.4% and 1.6%
respectively. Overall, the incremental cost for reducing one
patient with complication(s) in the LH group compared to the
AH group was $8,938 and $35,750 for reducing one patient with
major complication(s).
Based on this data, it is not clear which costs are really
associated with the actual cost difference between both treatment
modalities. There is significant variability between studies in the
range of cost components covered. Although some authors give
reasonable detail on economic data, [11,12,15,21] many give
scanty information or do not even specify the method of
measuring costs [14,16–20,22]. Strikingly, total costs were far
lower for the Chinese and Taiwanese study [19,26] compared to
the other included studies. Presumably, costs for hospital stay
and/or out patient department visits were much lower in Asia
than in Western countries. The direct costs were higher for LH,
whereas the indirect costs were lower than an AH. Nevertheless,
only one study collected data on indirect costs. Importantly,
previous reports stated that there might be societal benefits
associated with lower indirect cost for LH [7,16,22,30–34]. In
this analysis, cost drivers considered were the procedure
(including use of disposables) and hospital stay. Noticeably, there
is a wide range in these main cost drivers between the studies.
The wide range is caused by the duration of operation time and
the experience of the surgeons. Operating time is related to the
disease process (e.g. benign or malignant) and the occurrence of
additional procedures. A more extended hysterectomy in case of
a malignancy might have influence on the length of hospital stay,
as well. Inevitably, some of the studies have compared
inexperienced laparoscopic surgeons with experienced ‘open’
surgeons. As surgeons become more experienced with laparo-
scopic procedures, the length of operating time decreases
[35–37]. By training of surgeons in laparoscopy and using re-
usables instead of expensive disposables, procedure costs for LH
can be drastically reduced.
The same diversity as is found in costs between studies can be
seen in complication rates. In two studies [15,22] an overestima-
tion of complication rate might be shown in table 4, since only
number of complications were reported and not number of
patients with complications. Some studies reported major and
minor complications separately [12,14,15,21], with high minor
complication rates. A possible explanation for this phenomenon
can be the definition of minor or major complications.
Standardized criteria for defining minor and major complications
should be used in order to adequately compare complication rate
[38]. In most of the studies peroperative complications and short-
term post operative complications were reported and not long-
term complications. We therefore could not specify the occurrence
of long-term complications. Besides, the studies were selected on
bases of including costs in their report, not on morbidity as effect
measure. Since a part of the selected studies were of low
methodological quality (,10 points), the reported morbidity rates
might dissent from well-designed studies, powered on morbidity.
In comparison, in a large randomized controlled trial Garry et al.
demonstrated a major complication rate of 9.6% for LH and 6.2%
for AH, excluding conversions regarded as complications [39].
Reasons to convert a procedure are to avoid a complication to
occur or because of a complication that occurred. In the latter, the
complication is already recorded separately. Calculating a mean
effect, while some studies showed an opposite effect might give a
distorted picture. Again, reasons for this diversity are the
experience of the surgeons and the indication of performing a
hysterectomy. Inexperience with this advanced laparoscopic
procedure results in a higher peri-operative complication rate
during the learning curve [7].
The sub analyses of only RCTs indicated that the amount of
costs were higher or did not show additional effects when looking
at major complication rate. The latter means that implementation
of the laparoscopic technique is not cost effective as a standard
procedure. Minimization of selection bias and information bias
might be explanations for the higher morbidity rates in the LH
group and as a result not being cost effective as was found in RCTs
compared to all controlled trials. Randomization is important as it
helps reduce the possibility of bias [40]. Without randomization,
there may be a tendency for researchers to select these participants
for particular intervention groups they favor (i.e. selection bias). In
this way, systematically different estimates of treatment effects can
be yielded [41]. Moreover, most of the RCTs were rigorously set
up and monitored to ensure accurate registration of complications
and therefore safeguarding a systematic bias in reporting
frequency (i.e. information bias) by approach.
However, based on other criteria such as quality of life and
survival, LH might be more advantageous than AH. Results of two
large RCTs i.e.the GOG Lap2 study [42] and the LACE trial [43]
are expected in the near future with quality of life and survival as
primary endpoints. This will make more definitive conclusions
about these specific outcomes possible. Since the aim of the
present review was to globally explore differences in costs and
effects between both treatment arms independent of the
indication, the analyses of all controlled trials were more important
and decisive. Furthermore, because the relative differences were
analyzed instead of absolute differences the indication for removal
of the uterus and consequently the extent of the procedure was
therefore considered less relevant.
On average, an amount of $8,938 has to be invested to reduce
one complication when performing a LH in stead of an AH. The
explicit quantification of acceptable costs for a given benefit is
difficult to define. In other words, what costs are acceptable for
reducing one complication? From previous cost reports, a cut of
value of $100,000 for reducing one death seems cost effective and
therefore acceptable [44]. No reports are available, defining a cut
off value for reduction one complication. The National Institute
for Health and Clinical Excellence (NICE) has adopted a cost
effectiveness threshold range of $40,000–$60.000 per Quality
Adjusted Life Year (QALY) [45]. According to this guideline a
conservative range of $0–$20,000 to prevent one additional
complication represents an acceptable cost effectiveness ratio,
considering the (unknown) variation of complications and the
consequences of a complication in terms of prolonged hospital
stay, re-intervention and patient burden.
Cost and Effect Review
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The perception that laparoscopic procedures are more costly
than open procedures has been a major reason for the slow
acceptance of laparoscopic surgery. Important is whether LH is
more effective and more costly, with the added benefit worth the
added costs. From this study it can be concluded that the benefits
of shorter hospital stay in the LH group might compensate for the
increased procedure costs. Laparoscopic hysterectomy points in
the direction of cost effectiveness, however a broader perspective is
needed, including indirect costs and long term effects as survival
and quality of life for determining implications for practice.
Currently, a cost effectiveness evaluation of the two surgical
approaches is being conducted alongside a large multi-centre RCT
[46], complying with all guidelines.
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